Wei Wang

机构：ECSI Fibrotools (United States), Risun (China) · ORCID：0000-0001-5401-3331

发表论文 270 篇 · 总被引 4315 次 · h-index 33

代表论文

• HERB 2.0: an updated database integrating clinical and experimental evidence for traditional Chinese medicine (2024 · Nucleic Acids Research · 被引 60)
• Nanomedicines targeting activated immune cells and effector cells for rheumatoid arthritis treatment (2024 · Journal of Controlled Release · 被引 33)
• Norboldine improves cognitive impairment and pathological features in Alzheimer's disease by activating AMPK/GSK3β/Nrf2 signaling pathway (2024 · Journal of Ethnopharmacology · 被引 19)
• Advancements in MRSA treatment: the role of berberine in enhancing antibiotic therapy (2024 · BMC Microbiology · 被引 18)
• Deubiquitinase USP25 Alleviates Obesity-Induced Cardiac Remodeling and Dysfunction by Downregulating TAK1 and Reducing TAK1-Mediated Inflammation (2024 · JACC Basic to Translational Science · 被引 18)
• Unveiling the molecular mechanisms of Danggui-Shaoyao-San against Alzheimer’s disease in APP/PS1 mice via integrating proteomic and metabolomic approaches (2024 · Alzheimer s Research & Therapy · 被引 17)